Established in May 2016, The AMR Centre is a key part of the UK’s response to the global threat from Antimicrobial Resistance. Based at Alderley Park, The AMR Centre is a joint private-public initiative to support/accelerate the development of new antibiotics and diagnostics through a fully integrated development capability, offering translational R&D from pre-clinical hits through to clinical proof of concept.
Breaking News
Book giveaway: “Superbugs: An Arms Race Against Bacteria”
We're giving away 10 signed copies of Lord Jim O'Neill's book
AMR Centre Joins UK Trade Mission to Switzerland
The AMR Centre was delighted to be invited to join a recent UK trade mission to Switzerland.
AMR Centre joins the BEAM Alliance
The AMR Centre is delighted to join the BEAM Alliance, as an Associated Member.
Latest News
Dr. Pete Jackson Pushes Northern Powerhouse
The AMR Centre’s Executive Director, Dr. Pete Jackson, recently spoke and took part in a…
UK and Russian researchers join forces against AMR
Two of the key organisations in the UK and Russia leading efforts to combat the global…
AMR Centre participates in UK – China mission to tackle AMR
The AMR Centre recently participated in a UK – China partnership-building mission to…
Call for ‘renewed focus’ on deadly threat from antibiotic resistance
The spectre of a dwindling supply of effective antibiotics is considered one of the…
AMR Centre strikes third deal with EligoChem, focusing on peptides
The AMR Centre (AMRC) and EligoChem have entered into an agreement for the co-development…
AMR Centre attending Bio-Europe 2017
Come and meet us at Bio-Europe 2017.
AMR Centre proudly sponsoring 2017 BioInfect Conference
The AMR Centre is delighted to be sponsoring the 2017 BioInfect Conference.
England’s CMO highlights danger of AMR
England’s Chief Medical Officer has today warned about the threat posed by AntiMicrobial…
AMR Centre Medivir deal targets ‘superbug’ time-bomb
Microbiotix and The AMR Centre Announce Co-Development Agreement Targeting Drug Resistant…